NASDAQ: LFCRLifecore Biomedical Inc Stock Ownership - Who owns Lifecore Biomedical?
Insider buying vs selling
Have Lifecore Biomedical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul Josephs | Chief Executive Officer | 2026-05-20 | 40,413 | $4.57 | $184.69kSell |
| Thomas D. Salus | Chief Legal Administration | 2026-04-14 | 24,645 | $5.20 | $128.15kSell |
| Ryan David Lake | Chief Financial Officer | 2025-09-03 | 22,932 | $7.71 | $176.81kSell |
| Paul Josephs | Chief Executive Officer | 2025-07-08 | 54,857 | $8.19 | $449.28kSell |
| Ryan David Lake | Chief Financial Officer | 2025-07-08 | 32,806 | $8.19 | $268.68kSell |
| Thomas D. Salus | Chief Legal Administration | 2025-07-08 | 11,022 | $8.19 | $90.27kSell |
LFCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LFCR insiders and whales buy or sell their stock.
LFCR Shareholders
What type of owners hold Lifecore Biomedical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nelson Obus | 23.00% | 8,627,100 | $49.09M | Insider |
| Wynnefield Partners Small Cap Value LP I | 12.54% | 4,703,216 | $26.76M | Insider |
| Wynnefield Capital Inc | 12.54% | 4,703,216 | $26.76M | Institution |
| Christopher S. Kiper | 12.02% | 4,507,236 | $25.65M | Insider |
| Legion Partners Asset Management LLC | 11.90% | 4,461,823 | $25.39M | Institution |
| Greenhaven Road Investment Management LP | 9.43% | 3,537,573 | $20.13M | Institution |
| 325 Capital LLC | 5.77% | 2,162,466 | $12.30M | Institution |
| Blackrock Inc | 5.00% | 1,877,305 | $10.68M | Institution |
| Kenneth E. 1. Jones | 3.78% | 1,417,456 | $8.07M | Insider |
| Vanguard Capital Management LLC | 3.44% | 1,290,136 | $7.34M | Institution |
LFCR vs Pharmaceutical Stocks
Lifecore Biomedical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.